Here's another test of your graph-interpreting skills! Follow the link to see this graph at full size and indicate the parameter that best describes Curve 2.
1. Insulin Secretion
2. Postprandial glucose
3. Fasting glucose
4. Insulin Resistance
Managing Editor, Diabetes in Control
When Adding a GLP-1 for Patients Who Have Type 1 (off label use)
Female 43 years of age. Type 1 diabetes/insulin resistant, hyperglycemia, increasing insulin to manage glucose, but not covering well. Increasing appetite and gaining weight. GLP-1 (Victoza) added at 1/2 recommended start dose for people who have type 2 diabetes, which is 0.6mg, so patient started at 0.3mg daily. Patient started having hypoglycemic reactions, most often postprandially and nocturnally.
Read More »Metformin for Prediabetes: Success
In a controlled trial, 600 overweight and obese people with prediabetes were given metformin.
Read More »LDL-C Levels and Cardiovascular Risk
What is the best strategy to target LDL-C levels and improve cardiovascular outcomes?
Read More »Type I Diabetes Mellitus: A Triple Therapy Approach
What are the benefits of dapagliflozin for type 1 when added to an insulin-liraglutide regimen?
Read More »Liraglutide Use in Heart Failure Patients
Cardioprotective effects of the drug are focus of research.
Read More »Effect of Processed and Unprocessed Meats in Diabetes
Can meat consumption increase glucose intolerance and insulin resistance?
Read More »Impact of Carbohydrates in Diabetes Patients
Are very-low carbohydrate, low saturated fat diets the best choice for A1c control?
Read More »C-Peptide Levels in Diabetes Management
Can C-peptide help attain adequate glycemic control in diabetes patients?
Read More »Delaying Parkinson’s Disease Onset with Statin Therapy
Can statins provide neuroprotective properties in diabetes patients?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.